Ritgerðarsamkeppni og DNA dagur 2016

DNA dagurinn er haldinn í kring um 24. apríl ár hvert. Markmið DNA dagsins er að kynna mannerfðafræði fyrir nemendum, kennurum og foreldrum og af því tilefni er efnt til ritgerðarsamkeppni meðal unglinga 14 – 19 ára. Skrifa má á ensku eða öðru tungumáli. Veitt verða verðlaun fyrir bestu ritgerðina frá íslenskum nemendum. Verðlaunaafhending fer fram á DNA deginum íslenska sem verður þann 25. apríl 2016  í Öskju, kl. 16-17.30. Mannis hvetur kennara, nema og foreldra til að koma.

Hér að neðan eru ritgerðarefnin í ár. Lengd ritgerðarinnar má ekki fara yfir 750 orð og ein mynd má vera. Lokadagur fyrir skil er 31. mars. Hægt er að senda þær til mannis@mannis.is eða hingað http://www.dnaday.eu/641.0.html.

One of the following questions must be answered:

1. Choose a genetic test that is currently available for a condition or disease that does not cause symptoms until adulthood (i.e., an adult-onset condition such as hereditary breast cancer). Describe how the test works and how certain the test results are.
Then, either defend or refute the recommendation below from ESHG on  „Genetic testing in asymptomatic minors”
:
„Presymptomatic and predictive genetic testing of minors for conditions with adult-onset is acceptable only if preventive actions (e.g. preventive surgery or early detection aimed at therapeutic interventions) can be initiated before adulthood. Otherwise pre symptomatic and predictive genetic testing in minors for adult-onset disorders should be deferred until the person has the maturity and competence to understand the nature of the decision and its implications.“ 

or

2. Genomics is one of the main technologies that will facilitate personalized (or precision) medicine. In order to maximize the potential for personalized medicine, many people now advocate a big data approach. The future they see is that data from individuals held in  electronic medical records, may be coupled with other information from wearable sensors as well as their biological samples held in DNA biobanks.  Do you agree that the collection of biological samples from entire populations in large biobank facilities is a good idea to better understand the link between genomic markers and correct prevention/curative treatment? Is this the future of personalized medicine or do you see arguments not to share private information so widely?